Myopia – Medxy AI

$LISA MRS Formula Outperforms Existing Standards for IOL Calculation in Post-Refractive Surgery Patients, Especially in High Myopia$

news Ophthalmology

LISA MRS Formula Outperforms Existing Standards for IOL Calculation in Post-Refractive Surgery Patients, Especially in High Myopia

By MedXY 03/19/2026

A new IOL power calculation formula, LISA MRS, demonstrates superior accuracy for cataract patients with prior myopic refractive surgery, significantly outperforming existing formulas in eyes with axial lengths of 28 mm or greater by utilizing posterior corneal radius data.

news Ophthalmology Pediatrics

Understanding the FDA’s Rejection of SYD-101: Navigating the Challenges in Pediatric Myopia Treatment

By MedXY 11/04/2025

The FDA has rejected Sydnexis's low-dose atropine eye drop SYD-101 for controlling childhood myopia progression despite promising trial results, highlighting challenges in demonstrating long-term efficacy and clinical significance in new pediatric myopia therapies.

news Otorhinolaryngology Specialties

Screen Time and Young Eyes: Why Early Visual Development Deserves More Attention

By MedXY 07/27/2025

Prolonged electronic screen use in infants and toddlers can impact eye health and development. Here's what science reveals, common myths, and expert-backed recommendations for parents.